导师风采
王露楠

个人信息

Personal Information

  • 性别:女
  • 导师类型:博士生导师
  • 职称:研究员
  • 该职称任职时间:20090801

联系方式

Contact Information

  • 所属院系:国家卫生健康委临床检验中心
  • 所属专业:
  • 邮箱 : lnwang@nccl.org.cn
  • 工作电话 : 01085133609

个人简介

Personal Profile

王露楠 研究员,博士,博士生导师。1990年毕业于北京医科大学药学院,1990 年以来在国家卫生健康委临床检验中心一直从事免疫学、分子生物学的质量控制和标准化研究工作,多次获得北京市科技进步奖、中华医学会医学科学技术奖。社会任职包括国家卫生标准委员会血液标准专业委员会委员、中华预防医学会血液安全专业委员会常务委员。

团队简介

Team Profile

待补充更新

  • 研究方向Research Directions
临床检验诊断学,传染性疾病分子和血清学检测标准化,隐匿性乙肝分子机制的研究
  • 在校研究生Current Graduate Students

硕士研究生 4 名,博士研究生 2 名

  • 科研项目Research Projects
# 项目名称 起止日期 金额 项目类型 本人角色
1新型冠状病毒疫苗大规模使用的免疫策略研究2021-11-30 —— 2023-12-3198.0主持在研的国家或省部级科研项目主持者
2乙型肝炎病毒S蛋白跨膜结构域突变促进隐匿性乙型肝炎病毒感染的机制研究2022-01-01 —— 2024-12-3120.0主持在研的国家或省部级科研项目主持者
3血液安全保障及新产品新技术研究2021-10-20 —— 2025-12-31400.0主持在研的国家或省部级科研项目主持者
  • 发表论文Papers
# 论文题目 期刊名称 发表年份 论文署名
1Occult HBV infection inChinese blood donors: role of N-glycosylation mutations and amino acidsubstitutions in S protein transmembrane domainsEmerging Microbes & Infections2019-08通讯作者
2Naturally occurring pre-S mutations promote occult HBV infection by affecting pre-S2/S promoter activityAntiviral Res2022-12通讯作者
3Nucleic acid testing andmolecular characterization of HIV infections.European Journal of Clinical Microbiology & Infectious Diseases2019-05通讯作者
4Demographic characteristics oftransfusion-transmitted infections among blood donorsin ChinaBMC Infectious Diseases2019-01通讯作者
5Low seroprevalence of hepatitis delta virus co-infection in hepatitis B virus-infected blood donors in China: A multicenter studyFront Microbiol2022-07通讯作者
6Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma SamplesMicrobiol Spectr2022-04通讯作者
7Evaluation of ELISA and CLIA for Treponema pallidum specific antibody detection in China: A multicenter studyJ Microbiol Methods2019-02通讯作者
8Coronavirus Disease 2019: Coronaviruses and Blood SafetyTransfus Med Rev2020-04通讯作者
9Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood DonationsEmerg Infect Dis2020-07通讯作者
10Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasuresRev Med Virol2020-03通讯作者
11A Strategy for Screening and Confirmation of HTLV-1/2 Infections in Low-Endemic AreasFront Microbiol2020-11通讯作者
12Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and ConsequencesInternational Journal of Biological Sciences2021-04通讯作者
13Comparison of seven commercial SARS-CoV-2 nucleic acid detection reagents with pseudovirus as quality control material.J Mol Diagn2021-03通讯作者
14HIV-1 molecular epidemiology and drug resistance-associated mutations among treatment-na?ve blood donors in ChinaSci Rep2020-01通讯作者
15No evidence of SARS-CoV-2 RNA among blood donors: A multicenter study in Hubei, ChinaTransfusion2020-09通讯作者
16Molecular characterization of hepatitis C virus for subtype determination and resistance-associated substitutions detection among Chinese voluntary blood donorsAntiviral Res2020-11通讯作者
17A study based on four immunoassays: Hepatitis C virus antibody against different antigens may have unequal contributions to detectionVirol J2021-01通讯作者
18新型冠状病毒核酸混采对检测结果的影响中华检验医学杂2021-05通讯作者
19HIV-1 gp41 genetic diversity and enfuvirtide resistance-associated mutations among enfuvirtide-na?ve patients in southern ChinaVirus Res2021-11通讯作者
20Hepatitis B virus (HBV) preS region: Clinical implications and applications.Rev Med Virol2020-12通讯作者
21Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide surveyRetrovirology2021-02通讯作者
22The prevalence of antibodies to SARS-CoV-2 among blood donors in China.Nat Commun .2021-03通讯作者
23新型冠状病毒核酸血液筛查系统的检测性能评价国际病毒学杂志2020-06通讯作者
24Quantitative Evaluation of theTranscriptional Activity of Steroid Hormone Receptor Mutants and Variants Usinga Single Vector With Two Reporters and a Receptor Expression Cassette.Front Endocrinol2020-07通讯作者
25CDK4/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulating SKP2 dependent ACE2 degradationAntiviral Res2023-06通讯作者
26Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infectionEmerg Microbes Infect2022-12通讯作者
27Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in ChinaViruses2022-01通讯作者
28Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma SamplesMicrobiol Spectr2022-08王露楠
29Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infectionFront Microbiol2022-11通讯作者
30Development and validation of a duplex real-time PCR for the rapid detection and quantitation of HTLV-1Virol J2023-01通讯作者
31Serosurvey for SARS-CoV-2 among blood donors in Wuhan, China from September to December 2019Protein & Cell2023-01通讯作者
32A study based on four immunoassays: Hepatitis C virus antibody against different antigens may have unequal contributions to detectionVirol J2021-01通讯作者
33osttranslational modifications of ACE2 protein: Implications for SARS-CoV-2 infection and beyondJ Med Virol2023-12通讯作者
34Posttranslational modifications of ACE2 protein: Implications for SARS-CoV-2 infection and beyondJ Med Virol2023-12通讯作者
35Nuermaimait,et al. Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional studyHum Vaccin Immun other2023-12通讯作者
36Genetic typing and intrafamilial transmission of human T-lymphotropic virus type 1 in non-endemic areas of ChinaFront Microbiol2023-12通讯作者
37he role of sex hormones and receptors in HBV infection and development of HBV-related HCCJ Med Virol2023-12通讯作者
38我国血站血液检测实验室检测能力基本情况分析中国输血杂志2022-07通讯作者
39无偿献血者中HIV阳性者的病毒载量分析2019-03通讯作者
40我国OBI献血者中乙型肝炎病毒BCP/前C区及C区的分子特征国际病毒学杂志2022-05通讯作者
41血液筛查实验室HBsAg检测的室间质量评价国际病毒学杂志2023-02通讯作者
  • 科研获奖Research Awards


  • 研究成果Research Findings
# 成果类型 项目/专利/新品种名称
1作为主创人员获得授权的发明专利和新品种用于检测HLA-A29等位基因的UAP寡核苷酸、试剂盒和方法